Jensen K M, Dahl J B
Pharmacokinetic Laboratory, Dumex Ltd., Copenhagen, Denmark.
Arzneimittelforschung. 1994 Aug;44(8):951-3.
The plasma profiles of nitroglycerin (glyceryl trinitrate, GTN, CAS 55-63-0) and its dinitrate metabolites (1,2-GDN and 1,3-GDN) were estimated after sublingual administration of GTN tablets 0.5 mg (Nitromex) given in single doses to 20 volunteers. Blood samples (totally 20) were collected to 2 h after administration, and the plasma concentrations of GTN, 1,2-GDN, and 1,3-GDN were measured simultaneously by gas chromatography. The pharmacokinetic parameters, Cmax, tmax, t1/2, and the dinitrate ratio (AUC1,2-GDN/AUC1,3-GDN) were determined for each subject. The plasma concentrations of GTN reached a maximum of 1.38 ng/ml (mean) (range: 0.32-3.18 ng/ml) after 4.9 min (mean) (range: 3-8 min). The plasma concentrations of 1,2-GDN and 1,3-GDN reached a maximum of 3.11 ng/ml (mean) (range: 1.14-5.44 ng/ml) and 0.70 ng/ml (mean) (range: 0.33-1.19 ng/ml) after 13.7 min (mean) (range: 8-40 min) and 17.6 min (mean) (range: 8-40 min). The t1/2 values (mean) were 3.3, 35.5, and 38.1 min for GTN, 1,2-GDN, and 1,3-GDN, respectively. The dinitrate ratio was estimated to be 4.1 (mean).
对20名志愿者单次舌下含服0.5毫克硝酸甘油片(Nitromex)后,评估了硝酸甘油(三硝酸甘油酯,GTN,化学物质登记号55 - 63 - 0)及其二硝酸盐代谢产物(1,2 - GDN和1,3 - GDN)的血浆浓度变化情况。给药后2小时内采集血样(共20份),采用气相色谱法同时测定血浆中GTN、1,2 - GDN和1,3 - GDN的浓度。为每位受试者确定了药代动力学参数,包括Cmax(最大浓度)、tmax(达峰时间)、t1/2(半衰期)以及二硝酸盐比率(AUC1,2 - GDN/AUC1,3 - GDN)。GTN血浆浓度在4.9分钟(均值)(范围:3 - 8分钟)后达到最高值1.38纳克/毫升(均值)(范围:0.32 - 3.18纳克/毫升)。1,2 - GDN和1,3 - GDN的血浆浓度分别在13.7分钟(均值)(范围:8 - 40分钟)和17.6分钟(均值)(范围:8 - 40分钟)后达到最高值3.11纳克/毫升(均值)(范围:1.14 - 5.44纳克/毫升)和0.70纳克/毫升(均值)(范围:0.33 - 1.19纳克/毫升)。GTN、1,2 - GDN和1,3 - GDN的t1/2值(均值)分别为3.3分钟、35.5分钟和38.1分钟。二硝酸盐比率估计为4.1(均值)。